Why Incyte Corporation (INCY) stock moved
Incyte Corporation (INCY) shares fell 1.4% to $115.65 as of July 21, 2026, a modest decline from the prior close of $117.25. BestStocks flagged the session as a major change for INCY. Below, we break down what changed for INCY, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
INCY fell 1.4% to $115.65
INCY fell 1.4% in its latest session, moving from $117.25 to $115.65.
What it means for Incyte Corporation investors
For Incyte Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Incyte Corporation (INCY) moved +1.07% from $117.26 to $118.52 on 2026-07-09, reaching a new 30-day high; INCY moved +2.10% from $115.62 to $118.05 on 2026-07-07. Weighing against that: Negative session, down 1.4%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $113.09, implying -2.2% downside from $115.65. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 7 days out, the next report is the most likely near-term test of the move.
INCY price reaction
INCY last traded at $115.65, down $1.60 (-1.36%) from the previous close of $117.25. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $103.66 and $118.52, and it currently sits about 81% of the way up that band.
Bullish and bearish analyst opinions on Incyte Corporation (INCY)
The consensus analyst price target on Incyte Corporation (INCY) is $113.09, 2.2% below the recent $115.65. Over the past 90 days analysts logged 1 upgrade, 12 maintains, and 0 downgrades. Here is how the bullish and bearish cases on INCY line up.
The bullish case
- The Street's most bullish target is $140.00 (+21.1%).
- 1 analyst upgrade in the past 90 days, most recently BMO Capital to Market Perform (2026-06-22).
- Incyte Corporation (INCY) moved +1.07% from $117.26 to $118.52 on 2026-07-09, reaching a new 30-day high.
- INCY moved +2.10% from $115.62 to $118.05 on 2026-07-07.
The bearish case
- The consensus analyst price target of $113.09 sits 2.2% below the recent $115.65, so the average target sees limited room to run.
- The most bearish analyst target is $99.00 (-14.4%).
- Negative session, down 1.4%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for INCY
Frequently asked questions about INCY
Why did Incyte Corporation (INCY) stock move?
INCY fell 1.4% to $115.65. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did INCY stock fall?
INCY lost 1.36% ($1.60) versus the prior close of $117.25, last trading at $115.65 on 0.7× average volume.
When is Incyte Corporation's next earnings date?
INCY's next earnings report is estimated for 2026-07-28 — about 7 days away.
What is the analyst price target for INCY?
The consensus analyst price target for INCY is $113.09, about 2.2% below the current $115.65. Over the past 90 days, analysts recorded 1 upgrade, 12 maintains, and 0 downgrades.
How BestStocks tracks INCY
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared INCY-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for INCY, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.